中国立法者周日开始起草疫苗管理法草案,以加强对该行业的监督。
The draft was submitted for first review to the bi-monthly
legislative4 session of the
Standing5 Committee of the National People's Congress, which opened Sunday.
Basic research and application research on
vaccines6 should be supported, the draft says, noting that the development, production and reserves of vaccines for major diseases should be regarded as national strategies.
The draft
tightens7 control over access to vaccine production and sales, listing additional requirements separate from those for the
pharmaceutical8 industry.
Those in major job positions in vaccine-producing companies should pass a qualification review, especially in terms of their credit records, professional backgrounds and experience in the industry, according to the draft.
Every
batch9 of vaccines should be examined by
authorized10 institutions before being released to the market, the draft said.
Making
specialized11 regulations on the industry, the law could help vaccine-producing companies improve management and production quality, said Tang Minhao, head of a food and drug research organization based in Shanghai.
The draft also elaborates on the responsibilities of related government departments, demanding an information sharing
mechanism12 and disclosure of vaccine safety information.